Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Science (New York, N.Y.)
|
August 22, 2020
Immunotherapy with a sting
Thomas F Gajewski, Emily F Higgs
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Synergistic innate immune activation and anti-tumor immunity through combined STING and TLR4 stimulation
Emily F Higgs, Thomas F Gajewski
Journal for Immunotherapy of Cancer
|
June 15, 2022
Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration
Emily F Higgs, Riyue Bao, Ken Hatogai, et al.
Journal for Immunotherapy of Cancer
|
October 1, 2021
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Robin Reschke, Jovian Yu, Blake Flood, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy
Santiago Acero-Bedoya, Emily F Higgs, Anna C Martinez, et al.
Immunological Reviews
|
July 30, 2019
STING pathway agonism as a cancer therapeutic
Blake A Flood, Emily F Higgs, Shuyin Li, et al.
Nature Communications
|
February 1, 2020
Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
Jason B Williams, Shuyin Li, Emily F Higgs, et al.
Biopreservation and Biobanking
|
June 30, 2022
Insights from a Rapidly Implemented COVID-19 Biobank Using Electronic Consent and Informatics Tools
Emily F Higgs, Blake A Flood, Athalia R Pyzer, et al.
Cancer Immunology Research
|
January 14, 2025
PKCδ Germline Variants and Genetic Deletion in Mice Augment Antitumor Immunity through Regulation of Myeloid Cells
Kyle R Cron, Ayelet Sivan, Keston Aquino-Michaels, et al.
Cell Reports
|
April 24, 2024
Batf3<sup>+</sup> DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
Andrea Ziblat, Brendan L Horton, Emily F Higgs, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Science (New York, N.Y.)
|
August 22, 2020
Immunotherapy with a sting
Thomas F Gajewski, Emily F Higgs
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Synergistic innate immune activation and anti-tumor immunity through combined STING and TLR4 stimulation
Emily F Higgs, Thomas F Gajewski
Journal for Immunotherapy of Cancer
|
June 15, 2022
Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration
Emily F Higgs, Riyue Bao, Ken Hatogai, et al.
Journal for Immunotherapy of Cancer
|
October 1, 2021
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Robin Reschke, Jovian Yu, Blake Flood, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy
Santiago Acero-Bedoya, Emily F Higgs, Anna C Martinez, et al.
Immunological Reviews
|
July 30, 2019
STING pathway agonism as a cancer therapeutic
Blake A Flood, Emily F Higgs, Shuyin Li, et al.
Nature Communications
|
February 1, 2020
Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
Jason B Williams, Shuyin Li, Emily F Higgs, et al.
Biopreservation and Biobanking
|
June 30, 2022
Insights from a Rapidly Implemented COVID-19 Biobank Using Electronic Consent and Informatics Tools
Emily F Higgs, Blake A Flood, Athalia R Pyzer, et al.
Cancer Immunology Research
|
January 14, 2025
PKCδ Germline Variants and Genetic Deletion in Mice Augment Antitumor Immunity through Regulation of Myeloid Cells
Kyle R Cron, Ayelet Sivan, Keston Aquino-Michaels, et al.
Cell Reports
|
April 24, 2024
Batf3<sup>+</sup> DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
Andrea Ziblat, Brendan L Horton, Emily F Higgs, et al.
Page
of 2